ASP Isotopes Inc. (NASDAQ:ASPI) Stake Raised by Geode Capital Management LLC

Geode Capital Management LLC lifted its holdings in shares of ASP Isotopes Inc. (NASDAQ:ASPI) by 42.7% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,118,423 shares of the company’s stock after buying an additional 334,836 shares during the period. Geode Capital Management LLC owned approximately 1.57% of ASP Isotopes worth $3,110,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in ASPI. Telemark Asset Management LLC acquired a new position in ASP Isotopes during the 3rd quarter worth $4,726,000. Fiera Capital Corp acquired a new stake in ASP Isotopes in the third quarter worth about $723,000. BNP PARIBAS ASSET MANAGEMENT Holding S.A. acquired a new stake in ASP Isotopes in the third quarter worth about $6,249,000. GSA Capital Partners LLP increased its stake in ASP Isotopes by 96.0% during the 3rd quarter. GSA Capital Partners LLP now owns 770,989 shares of the company’s stock valued at $2,143,000 after buying an additional 377,721 shares during the period. Finally, Marshall Wace LLP raised its position in shares of ASP Isotopes by 389.6% during the 2nd quarter. Marshall Wace LLP now owns 545,072 shares of the company’s stock worth $1,668,000 after buying an additional 433,734 shares in the last quarter. 16.80% of the stock is owned by institutional investors.

Analyst Ratings Changes

ASPI has been the subject of several recent analyst reports. Canaccord Genuity Group reiterated a “buy” rating and issued a $4.50 price objective on shares of ASP Isotopes in a report on Friday, October 18th. Canaccord Genuity Group began coverage on ASP Isotopes in a research note on Friday, October 4th. They set a “buy” rating and a $4.50 price target for the company.

ASP Isotopes Price Performance

Shares of NASDAQ ASPI opened at $5.03 on Tuesday. ASP Isotopes Inc. has a twelve month low of $1.72 and a twelve month high of $9.33. The company has a current ratio of 7.55, a quick ratio of 7.54 and a debt-to-equity ratio of 0.80. The firm has a 50-day moving average of $5.93 and a two-hundred day moving average of $3.97. The company has a market capitalization of $359.09 million, a price-to-earnings ratio of -8.25 and a beta of 3.48.

ASP Isotopes Company Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235.